🍄 Josh Bartch is the CEO of Mydecine Innovations Group, a psychedelics company that is researching naturally sourced psychedelic therapeutics targeting PTSD and smoking cessation. In this episode of The Integration Conversation, Josh joins us for a full hour and tells us about Mydecine's clinical trials, its research on functional mushrooms, and makes his pitch for why Mydecine is undervalued relative to its peers.
Questions we answer:
🔥 Invest in Psychedelic Startups with Us 🔥
go to https://theintegration.co and click on "invest in psychedelic startups"
The Integration Conversation is a podcast that covers the emerging psychedelics industry from a business perspective, and aims to be your number 1 resource for investing in psychedelics, psychedelic investing and psychedelic business.
⛓ All our links:
https://theintegration.co
📝 My notes on psychedelic investing:
https://brompersonal.s3-us-west-2.amazonaws.com/assets/broms-notes-psychedelic-investing.pdf
🎧 Listen on Spotify and other podcast platforms:
https://anchor.fm/theintegrationco
🐦 brom on twitter:
https://twitter.com/therealbrom
🎇 Clips and other stuff on Instagram:
https://instagram.com/theintegrationco
⏰ Timestamps:
Disclaimer: This video is not financial advice. Brom holds shares in Mydecine and other psychedelic stocks.
View all episodes
By Brom Rector and XEIA
5
66 ratings
🍄 Josh Bartch is the CEO of Mydecine Innovations Group, a psychedelics company that is researching naturally sourced psychedelic therapeutics targeting PTSD and smoking cessation. In this episode of The Integration Conversation, Josh joins us for a full hour and tells us about Mydecine's clinical trials, its research on functional mushrooms, and makes his pitch for why Mydecine is undervalued relative to its peers.
Questions we answer:
🔥 Invest in Psychedelic Startups with Us 🔥
go to https://theintegration.co and click on "invest in psychedelic startups"
The Integration Conversation is a podcast that covers the emerging psychedelics industry from a business perspective, and aims to be your number 1 resource for investing in psychedelics, psychedelic investing and psychedelic business.
⛓ All our links:
https://theintegration.co
📝 My notes on psychedelic investing:
https://brompersonal.s3-us-west-2.amazonaws.com/assets/broms-notes-psychedelic-investing.pdf
🎧 Listen on Spotify and other podcast platforms:
https://anchor.fm/theintegrationco
🐦 brom on twitter:
https://twitter.com/therealbrom
🎇 Clips and other stuff on Instagram:
https://instagram.com/theintegrationco
⏰ Timestamps:
Disclaimer: This video is not financial advice. Brom holds shares in Mydecine and other psychedelic stocks.
8,901 Listeners
8,778 Listeners